20558 ⎘
Medicinal preparations containing organic active ingredients; Carbohydrates; Sugars; Derivatives thereof; Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
CHONDROITIN SULFATE POLYSACCHARIDE, AND SEMI-SYNTHETIC PREPARATION METHOD THEREFOR AND USE THEREOF
#2METHOD FOR IMPROVING ATOPIC DERMATITIS BY USING A COMPOSITION COMPRISING LOW-MOLECULAR-WEIGHT FUCOIDAN
#3ENERGY DRINK COMPOSITION
#4CARTILAGE REGENERATION COMPOSITION
#5RECOMBINANT FUSION POLYPEPTIDES FOR SECRETING SOLUBLE, HETEROLOGOUS CARGO
#6TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#7TREATMENT OF PSORIASIS, PSORIATIC ARTHRITIS AND DERMATITIS
#8Compositions and Methods to Protect and Enhance Structural and Functional Integrity of the Intestinal Glycocalyx
#9GASTROINTESTINAL PROTECTANT COMPOSITION
#10Influx Vitamins and Drinks, with Zinc Ionophoric Influx
#11COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
#12COMPOSITIONS AND METHODS FOR TREATING CYSTITIS
#13Vascular Constructs
#14METHODS AND COMPOSITIONS FOR IMPROVING WOUND HEALING
#15EYE DROP FORMULATIONS CONTAINING CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN OR DISCOMFORT
#16NUTRACEUTICAL COMPOSITION FOR COMBATING AGING IN HUMAN AND NON-HUMAN ANIMALS AND BEVERAGES AND/OR FOOD PRODUCTS AND/OR FOOD SUPPLEMENTS CONTAINING THE SAME
#17NUTRACEUTICAL COMPOSITION FOR COMBATING AGING IN HUMAN AND NON-HUMAN ANIMALS AND BEVERAGES AND/OR FOOD PRODUCTS AND/OR FOOD SUPPLEMENTS CONTAINING THE SAME
#18EFFICIENT TRANSDERMAL DELIVERY SYSTEM FOR ACIDIC GROUP-CONTAINING BIOMATERIAL
#19SULFATED GLYCOSAMINOGLYCAN COMPOUNDS, METHODS, AND USES THEREOF
#20Composition Comprising a Combination of Lactoferrin and a Sulphated Polysaccharide
#21STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS
#22STORAGE STABLE FORMULATIONS OF SULFATED GLYCOSAMINOGLYCANS AND FRAGMENTS DERIVED THEREFROM FOR THE TREATMENT OF PAIN AND OTHER MEDICAL CONDITIONS
#23TREATMENT OF BONE MARROW PATHOLOGIES WITH POLYSUFATED POLYSACCHARIDES
#24DISRUPTION OF SONIC HEDGEHOG-SURF4 INTERACTION FOR CANCER TREATMENT
#25OPHTHALMIC COMPOSITION
#26Stable Soft Chews, and Methods to Produce Same
#27MEDICAL USE OF TAFOXIPARIN
#28ANTIVIRAL SULFATED CHITOSAN DERIVATIVES
#29SYSTEMS AND METHODS USING SULFATED GLYCOSAMINOGLYCANS (GAGs) AND GAG ANALOGS TO TREAT OR PREVENT MONKEYPOX (MPOX)
#30REPAIR OF ENDOTHELIAL GLYCOCALYX
#31COLLAGEN HYDROLYSATE COMPOSITION FOR REDUCING JOINT PAIN AFTER EXERCISE
#32COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2
#33THERAPEUTIC COMBINATIONS FOR INFLAMMATORY CONDITIONS AND DISORDERS
#34COMPOSITIONS INCORPORATING SULFATED POLYSACCHARIDES FOR INHIBITING SARS-COV-2
#35Compositions and Methods to Protect and Enhance Structural and Functional Integrity of the Intestinal Glycocalyx
#36HYDROGEL FORMULATION USED AS VITREOUS SUBSTITUTE AND PRODUCTION METHOD THEREOF
#37Low-Molecular-Weight HE800 Exopolysaccharide Derivatives with Anti-Cancer Properties and Uses Thereof
#38METHODS FOR POTENTIATING CANCER TREATMENT USING IONIZING RADIATION
#39LOW ENDOTOXIN FUCAN COMPOSITIONS, SYSTEMS AND METHODS
#40USE OF DEXTRAN SULFATE
#41PHARMACEUTICAL COMPOSITION FOR INCREASING MITOCHONDRIAL ACTIVITY AND/OR IMPROVING ADIPONECTIN PRODUCTION
#42METHOD FOR MODULATING ENDOTHELIAL GLYCOCALYX STRUCTURE
#43COMPOSITION FOR THE PREVENTION AND/OR TREATMENT OF GASTRIC AND ESOPHAGEAL DISEASES
#44Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
#45FUCAN AND MODIFIED FUCAN COMPOSITIONS FOR THE TREATMENT OF CONDITIONS RELATED TO CAPSULAR CONTRACTURE AND TO INHIBITING FIBROUS GROWTH AROUND OR ON TRANSPLANTS
#46Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
#47DRUG FOR PREVENTING, ALLEVIATING OR TREATING MUCOSAL ADHESION AND USE THEREOF
#48BOTANICAL EXTRACTS TO INHIBIT VIRUS INFECTION
#49ANTIVIRAL AGENTS FOR PREVENTION OR TREATMENT OF PATHOLOGIES CAUSED BY ALPHA- AND/OR BETA-CORONAVIRUSES
#50HEPARAN SULFATE MIMETICS TO IMPROVE GLUCOSE CLEARANCE
#51CHLORELLA MANNOGALACTAN OR SULFATED CHLORELLA MANNOGALACTAN COMPOUND AND APPLICATION OF SULFATED CHLORELLA MANNOGALACTAN COMPOUND
#52USE OF CHONDROITIN SULFATE FOR RELIEVING OCULAR PAIN
#53USE OF SULFATE GLUCO-GALACTO-OLIGOSACCHARIDE IN PREPARATION OF ANTICOAGULANT AND/OR ANTITHROMBOTIC DRUG
#54ANTIVIRAL PHARMACEUTICAL COMPOSITION
#55Methods and Compositions for the Treatment of Pain and/or Inflammation
#56WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS
#57Use of chondroitin sulfate for relieving ocular pain
#58TREATMENT OF VIRUS INFECTIONS
#59SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF
#60Biocompatible Product Having A Matrix Comprising a Polysaccharide Co-Crosslinked With Chitosan
#61COMBINATION FOR TREATMENT OF THROMBOINFLAMMATION
#62Treatment of Bone Marrow Edema (Oedema) With Polysulfated Polysaccharides
#63RHAMNAN SULFATE-BASED THERAPEUTICS FOR NONALCOHOLIC FATTY LIVER DISEASE AND CIRCADIAN RHYTHM DISORDERS
#64NOVEL ARTHRITIS EMULGEL COMPOSITION AND ITS PREPARATION PROCESS
#65WATER-ACTIVATED MUCOADHESIVE COMPOSITIONS TO REDUCE INTESTINAL ABSORPTION OF NUTRIENTS
#66PH-responsive hydrogel and manufacturing method thereof
#67Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions
#68COMPOSITIONS AND METHODS FOR REVERSING AGE-ASSOCIATED DENDRITIC SPINE LOSS
#69BLENDED FORMULATIONS
#70TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE
#71REPAIR AND/OR RECONSTRUCTION OF INVERTEBRAL DISCS
#72NASAL SPRAY USING PENTOSAN POLYSULFATE AND MUCOPOLYSACCHARIDE POLYSULFATE FOR COVID-19 PREVENTION AND TREATMENT
#73TREATMENT OF PAIN WITH POLYSULFATED POLYSACCHARIDES
#74METHODS FOR PREVENTING CANCER RELAPSE
#75METHOD FOR IDENTIFYING AND/OR FOR OBTAINING AN ACTIVE SUBSTANCE FOR THE TREATMENT AND THERAPY OF FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS, AND USE OF AN ACTIVE SUBSTANCE FOR THE TREATMENT OF THIS DISEASE
#76CELLULAR GLYCOSAMINOGLYCAN COMPOSITIONS AND METHODS OF MAKING AND USING
#77TREATMENT OF FATTY LIVER DISEASES
#78SPRAYABLE ANTIVIRAL FORMULATION
#79TREATMENT OF POST-OPERATIVE JOINT PAIN WITH POLYSULFATED POLYSACCHARIDES
#80Ocular injector and methods for accessing suprachoroidal space of the eye
#81TOPICAL COMPOSITIONS
#82TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION
#83POLYSACCHARIDE COMPOSITION AND METHOD FOR REDUCING PROTEIN ADSORPTION
#84COMPOSITIONS COMPRISING A VEGETABLE CHONDROITIN OR AN ANALOGUE THEREOF AND THE USE THEREOF IN THE TREATMENT OF DISORDERS OF THE MUCOUS MEMBRANE OF THE ORAL, PHARYNGO-LARYNGEAL AND/OR GASTRO-OESOPHAGEAL TRACT
#85MEDICAL USE OF TAFOXIPARIN
#86COMPOSITIONS COMPRISING SULFATED POLYSACCHARIDES
#87TREATMENT OF CORONAVIRUS INFECTIONS
#88METHODS OF MAKING NON-AQUEOUS CHEWS
#89SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES
#90TREATMENT OF NERVOUS SYSTEM INJURY AND NEURODEGENERATIVE DISORDERS AND RELATED CONDITIONS
#91Extended release plastic formulation
#92CELL PROTECTIVE METHODS AND COMPOSITIONS
#93ANTIVIRAL PHARMACEUTICAL COMPOSITION
#94MODULATION OF FACTOR 11 EXPRESSION
#95LOW MOLECULAR WEIGHT CHONDROITIN SULFATE, COMPOSITION, PREPARATION METHOD AND USE THEREOF
#96Treatment of bone marrow pathologies with polysulfated polysaccharides
#97ANTIVIRAL PHARMACEUTICAL COMPOSITION
#98CONTACT LENS PRODUCT WITH CORNEA REPAIR FUNCTION
#99Marine Bacterial Exopolysaccharide Derivatives and Uses Thereof in the Treatment of Mucopolysaccharidoses
#100SOLID ORAL COMPOSITIONS COMPRISING COMPOSITE MONOLITHIC MATRICES FOR CHRONOTROPIC ADMINISTRATION OF ACTIVE INGREDIENTS IN THE GASTROINTESTINAL TRACT
#101POLYSACCHARIDE COMPOSITIONS AND THERAPEUTIC GELS
#102Treatment for coronavirus infection and associated cytokine toxicity
#103Regulated drug delivery via controlled degradable chondroitin sulfate particles
#104Ophthalmic Composition
#105Composition and method for treating cancer
#106HELP APHERESIS FOR THE TREATMENT OF SERIOUSLY ILL COVID-19 PATIENTS
#107DIAGNOSIS AND TREATMENT OF COVID-19
#108METHOD FOR ALLEVIATING ARTHRITIS USING EPIDERMAL GROWTH FACTOR
#109PHARMACEUTICAL COMPOSITION FOR TREATMENT OF ENVELOPED DNA OR RNA VIRUS INDUCED INFECTIONS AND DISORDERS
#110CXCL8 INHIBITORS FOR USE IN THE TREATMENT OF COVID-19
#111High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
#112ARTICLE OF MANUFACTURE COMPRISING LOCAL ANESTHETIC, BUFFER, AND GLYCOSAMINOGLYCAN IN SYRINGE WITH IMPROVED STABILITY
#113TREATMENT OF ACUTE RESPIRATORY DISEASE SYNDROME (ARDS) WITH POLYSULFATED POLYSACCHARIDES
#114IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT
#115TREATMENT OF SEPSIS AND HYPERCYTOKINEMIA
#116COMPOSITIONS AND METHODS FOR DEGENERATIVE DISC REGENERATION
#117Treatment for coronavirus infection and associated cytokine toxicity
#118Method for dissolving scars with dextran sulfate
#119Opthalmic Compositions for Treating Coronaviruses
#120Extended release plastic formulation
#121METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DISEASE
#122PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTING OR STOPPING METASTASES
#123SYNOVIAL FLUID SUBSTITUTES
#124COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#125BLENDED FORMULATIONS
#126MICROBIOME INTERVENTIONS
#127Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
#128TREATMENT OF BONE MARROW EDEMA (OEDEMA) WITH POLYSULFATED POLYSACCHARIDES
#129Methods of generating, repairing and/or maintaining connective tissue in vivo
#130PHARMACEUTICAL COMPOSITION
#131Ocular injector and methods for accessing suprachoroidal space of the eye
#132Printed Delivery Device Having Supplements
#133HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#134Stabilized aqueous composition comprising chondroitin sulfate and hyaluronic acid
#135ANTITHROMBOTIC COATING COMPOSITION AND ANTITHROMBOTIC COATING METHOD USING SAME
#136METHOD AND USE OF COMPOSITIONS COMPRISING LIGNOSULFONATE FOR ATTENUATION OF SARS-CoV-2 VIRUS REPLICATION
#137Clonal Hematopoiesis and Risk of Chronic Liver Disease
#138MEDICINAL AND/OR PHARMACEUTICAL COMPOSITIONS FOR INTRAVESICAL INSTILLATION, PREPARATION AND USE THEREOF
#139Liquid composition for use in the treatment of gastroesophageal reflux
#140NUTRITIONAL FORMULATION FOR CANCER PREVENTION
#141TREATMENT OF PATIENTS UNDER ANTIPLATELET MEDICATION EXPERIENCING ACUTE BLEEDING COMPLICATIONS DURING/AFTER SURGERY
#142HEMP EXTRACT AND METHODS OF USE THEREOF
#143Methods to Stabilize and Reverse Atherosclerotic Lesions by Sulfated Polysaccharides
#144Multi-efficacy traditional chinese medicine compound composition and application thereof in pharmaceutical preparations
#145Manifold With Biological Actives For Negative-Pressure Therapy
#146DEXTRAN SULFATE FOR INFLAMMATORY DERMATOSES
#147COMPOSITION FOR THE PROTECTION AND REPAIR OF THE BLOOD BRAIN BARRIER
#148OPHTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR TREATING OCULAR SURFACE DISEASE
#149CHONDROITIN SULFATE POLYSACCHARIDE, AND SEMI-SYNTHETIC PREPARATION METHOD THEREFOR AND USE THEREOF
#150TREATMENT EFFICIENCY EVALUATION
#151Application of Sulfated Polysaccharides in Resisting novel Coronavirus
#152COMPOSITION COMPRISING A COLLAGEN HYDROLYSATE AND A FUCOIDAN
#153METHOD FOR MITIGATION OF NON-ALCOHOLIC FATTY LIVER DISEASE BY USE OF A COMPOSITION COMPRISING SMALL-MOLECULE FUCOIDAN AND FUCOXANTHIN
#154Method for modulating endothelial glycocalyx structure
#155INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#156COMPOSITIONS COMPRISING DERMATAN SULFATE AND CHONDROITIN SULFATE AND USE THEREOF IN COSMETOLOGICAL COMPOSITIONS
#157Fucoidan hair growth agent
#158MULTILAYER DRUG DELIVERY COATING FOR CONTACT LENS
#159Methods for potentiating cancer treatment using ionizing radiation
#160COMPOSITION FOR INCREASING BIOLOGICAL ACTIVITY OF STEM CELLS USING MIXTURE 4F
#161COLLAGEN REPLACEMENT/REGENERATION FORMULATION AND USES THEREOF
#162Compositions and methods comprising growth factors, chondroitin and glucosamine for degenerative disc regeneration
#163Joint cavity injection preparation and use thereof
#164DERIVATIVES OF N-DESULFATED GLYCOSAMINOGLYCANS AND USE AS DRUGS
#165Treatment of pain with polysulfated polysaccharides
#166Compositions and methods for degenerative disc regeneration
#167Treatment of glaucoma
#168METHOD FOR REDUCING THE OCCURRENCE OF THROMBOSIS OR THROMBOEMBOLISM
#169Pharmaceutical composition comprising cyclodextrin complexes of anethole trithione or derivatives thereof
#170Low endotoxin fucan compositions, systems, and methods
#171High-molecular-weight fucans for treating fibrous adhesions and other diseases and conditions
#172Highly purified and/or modified fucan compositions for the treatment of fibrous adhesions
#173Highly purified fucans for the treatment of fibrous adhesions
#174Highly sulfated fucans for the treatment of fibrous adhesions
#175Methods and compositions for reversing or mitigating skin aging
#176Article of manufacture comprising local anesthetic, buffer, and glycosaminoglycan in syringe with improved stability
#177Cannabidiol Combination Compositions
#178Vascular constructs
#179COMPOSITION CONTAINING BECLOMETHASONE FOR THE PREVENTION AND THE TREATMENT OF BACTERIAL PROSTATITIS AND VAGINITIS
#180Compositions for oral administration of pentosan polysulfate in form of nanoparticles with improved intestinal absorption
#181Cell Expansion Methods and Therapeutic Compositions
#182Cell protective methods and compositions
#183Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
#184Methods for preventing a serious health consequence and/or tissue damage after exposure to ionizing radiation and/or chemotherapy
#185PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE
#186APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY
#187NOVEL PENTOSAN POLYSULFATE SODIUM PREPARATION
#188Modulation of factor 11 expression
#189Veterinary Supplement for Effecting Bone and Cartilage
#190Bladder instillation composition with increased storage stability and containing chondroitin sulfate (4.5 mg/ml), hyaluronic acid (16 mg/ml) and phosphate buffer (PH 6.1 to 7.9), for the treatment of cystitis
#191Bladder instillation composition containing chondroitin sulfate (20 mg/ml), hyaluronic acid (16 mg/ml) and a phosphate buffer (pH 6.1 to 7.9) with increased storage stability for treating cystitis
#192SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES
#193COMPOSITION FOR PROMOTING SECRETORY IGA SECRETION
#194Stabilized Glycosaminoglycan Preparations and Related Methods
#195Combination of a MAPK/ERK pathway inhibitor and a glycosaminoglycan for the treatment of cancer
#196Pet Food Supplement
#197Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#198COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING PROTEINURIA AND ENDOTHELIAL EROSION
#199Octasaccharides and uses thereof
#200Polysaccharides for the treatment of ocular conditions
#201Methods and compositions for the treatment of pain and/or inflammation
#202PHARMACEUTICAL COMPOSITIONS COMPRISING HEPARINOIDS AND METHODS FOR PREPARING THEREOF
#203Use of dextran sulfate
#204Derivatives of N-desulfated glycosaminoglycans and use as drugs
#205HYALURONIC ACID SYNTHESIS PROMOTER, METHOD FOR PROMOTING HYALURONIC ACID SYNTHESIS, AND CELL EVALUATION METHOD
#206DENDRITIC CELL IMMUNORECEPTOR AGONIST
#207Algal extract comprising sulphated and non-sulphated polyanionic polysaccharides and uses thereof
#208Glycosaminoglycan derivative and preparation method therefor and use thereof
#209Treatment of alphavirus-induced inflammation
#210BLENDED FORMULATIONS
#211METHOD OF DIAGNOSIS, PROGNOSIS OR TREATMENT OF NEURODEGENERATIVE DISEASES
#212F-fucoidan, desulfated F-fucoidan, and its processed derivatives in terms of desulfated oligo-fucose as inhibitors of gastrointestinal infection
#213Treatment of bone marrow edema (OEDEMA) with polysulfated polysaccharides
#214Multiphasic compositions
#215Treatment of post-operative joint pain with polysulfated polysaccharides
#216Water-soluble polysaccharide derivatives, process for their preparation, and their uses
#217OPHTHALMIC PRODUCT WITH CORNEA REPAIR FUNCTION
#218LIQUID COMPOSITION FOR USE IN THE TREATMENT OF THE MUCOSA OF THE ORO-PHARYNGO-LARYNGO-ESOPHAGEAL TRACT
#219APPARATUS AND FORMULATIONS FOR SUPRACHOROIDAL DRUG DELIVERY
#220Pentosan polysulfate and medicine containing pentosan polysulfate
#221Methods and compositions for the prevention and treatment of disease
#222IMMUNITY-BOOSTING AGENT, IMMUNO-THERAPEUTIC ANTI-CANCER AGENT, AND ANTI-CANCER THERAPY ADVERSE EFFECT MITIGATING AGENT CONTAINING ANTHOCYANIN-FUCOIDAN COMPLEX AS ACTIVE INGREDIENT
#223Compositions comprising sulfated polysaccharides
#224STABILIZED AQUEOUS COMPOSITION COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID
#225Pharmaceutical composition for prevention of recurrent urinary tract infection
#226PHARMACEUTICAL COMPOSITIONS AND METHODS RELATING TO INHIBITING FIBROUS ADHESIONS OR INFLAMMATORY DISEASE USING LOW SULPHATE FUCANS
#227SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF
#228SUCKABLE AND/OR MELT-IN-MOUTH TABLET BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND SALTS THEREOF FOR USE IN THE TREATMENT OF A SUBPOPULATION OF GERD PATIENTS
#229Cellular glycosaminoglycan compositions and methods of making and using
#230Methods and compositions for treatment of pigmented lesions
#231INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
#232Nutritional composition for treating or preventing impaired mobility
#233FUCOIDAN HAIR GROWTH AGENT
#234Ophthalmic pharmaceutical compositions and methods for treating ocular surface disease
#235Photo-coupled synergistically crosslinked hydrogel material and its composition, preparation method, use, product, and preparation kit
#236Mixture of fucosylated chondroitin sulfate oligosaccharides and method for rapidly producing the same
#237Treatment of bone marrow pathologies with polysufated polysaccharides
#238Compound composition with function of promoting bone and joint health and application thereof
#239METHODS AND COMPOSITIONS FOR TREATING CHRONIC RHINOSINUSITIS
#240Compositions and methods for preventing/treating metabolic syndrome
#241PRODUCTS AND METHODS ASSOCIATED WITH MULTIPLE SCLEROSIS AS A TRANSMISSIBLE PROTEIN MISFOLDING DISORDER
#242Derivatives of N-desulfated glycosaminoglycans and use as drugs
#243NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#244Compositions comprising sulfated polysaccharides
#245SHREDDED-MEAT-SHAPED PET FOOD AND PREPARATION METHOD THEREOF
#246Methods of treating spinal cord injury using a chondroitin sulfate proteoglycan (CSPG) reduction peptide (CRP) comprising a cell membrane penetrating domain, a CSPG binding domain, and a lysosome targeting domain
#247Composition having tissue-repairing activity, and use therefor
#248PHARMACEUTICAL COMPOUNDS COMPRISING MODIFIED FUCANS AND METHODS RELATING THERETO
#249METHODS OF GENERATING, REPAIRING AND/OR MAINTAINING CONNECTIVE TISSUE IN VIVO
#250Methods of Treating Ocular Disorders
#251DEVICE AND METHOD TO TREAT OR PREVENT JOINT DEGENERATION
#252HEPARIN-PEPTIDE BIOCONJUGATES AND USES THEREOF
#253Pentosan polysulfate, pharmaceutical composition, and anticoagulant
#254Compositions prepared from poultry and methods of their use
#255Methods for treating respiratory conditions using ionic aqueous polysaccharide compositions
#256SULPHATED XYLANS FOR TREATMENT OR PROPHYLAXIS OF RESPIRATORY DISEASES
#257Water-activated mucoadhesive compositions to reduce intestinal absorption of nutrients
#258AQUEOUS COMPOSITION DERIVED FROM SEAWATER AND SEAWEED
#259GlycoFix (Structurally And Functionally Repaired Endothelial Glycocalyx)
#260Medicines for topic use based on sulfated hyaluronic acid as activating or inhibiting agent of the cytokine activity
#261Modulation of Factor 11 expression
#262COMPOSITION FOR PREVENTING AND TREATING ARTHRITIS, INCLUDING DNA FRAGMENT MIXTURE AND MATRIX METALLOPROTEINASE PRODUCTION INHIBITOR
#263Combination of an oxidant and a photoactivator for the wounds
#264DRUG COMPOSITIONS
#265Compositions and methods for degenerative disc regeneration
#266Application of alginic acid sulfate in preparation of drugs and health care products for preventing and treating diseases caused by human papilloma viruses
#267NOVEL INTERSTITIAL THERAPY FOR IMMEDIATE SYMPTOM RELIEF AND CHRONIC THERAPY IN INTERSTITIAL CYSTITIS
#268EDIBLE SEMI-SOLID COMPOSITION FOR USE IN PATIENTS UNDERGOING ENDOSCOPY INCLUDING COLONOSCOPY
#269Chondroitin sulfate derivative and agent for treating bladder diseases
#270Inhibitors of ADAMTS4 or ADAMTS5 for use in preventing or treating cardiac remodeling and chronic heart failure
#271Process for the production of high-purity sulfated HA
#272Liquid composition for use in the treatment of gastroesophageal reflux
#273TREATMENT OF ALPHAVIRUS-INDUCED INFLAMMATION
#274COMPOSITION FOR PROMOTING SECRETORY IGA SECRETION
#275Biocompatible Hydrogel Compositions
#276Low polydispersity, low molecular weight biotechnological chondroitin sulfate with anti-inflammatory and antiarthritis activity and use thereof in the prevention of osteoarthritis
#277KEFIRAN FOR USE IN REGENERATIVE MEDICINE AND/OR TISSUE ENGINEERING
#278Methods to stabilize and reverse atherosclerotic lesions by sulfated polysaccharides
#279In situ gelling compositions for the treatment or prevention of inflammation and tissue damage
#280Compositions for the skin
#281NOVEL ACTIVE IMMUNOMODULATORY AGENT AND COMPOSITION CONTAINING SAME
#282Compositions and methods to affect skin irritation
#283COMPOSITIONS COMPRISING NANOPARTICLES DERIVED FROM WHOLE FRUIT
#284Compositions comprising sulfated polysaccharides and uses thereof
#285Unsaturated derivatives of polysaccharides, method of preparation thereof and use thereof
#286Compositions and methods for treating and preventing proteinuria and endothelial erosion
#287REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#288Methods and compositions for treatment of pigmented lesions
#289Fucoidan nanogels and methods of their use and manufacture
#290Vascular constructs
#291NON-ANTICOAGULANT SULFATED OR SULFONATED POLYSACCHARIDES
#292Compositions and methods to affect skin irritation
#293TABLET TO BE SUCKED AND/OR DISSOLVED IN THE MOUTH BASED ON HYALURONIC ACID AND CHONDROITIN SULPHATE AND THEIR SALTS
#294Methods for generating immunotolerant responses
#295STABILIZED AQUEOUS COMPOSITION COMPRISING CHONDROITIN SULFATE AND HYALURONIC ACID
#296Isolation and Identification of Glycosaminoglycans
#297Cysteine Peptide-Containing Health Drink
#298DRUG COMPOSITIONS
#299Formulations containing clopidogrel and sulfoalkyl ether cyclodextrin and methods of use
#300PENTOSAN POLYSULFATE SODIUM FOR THE TREATMENT OF SICKLE CELL DISEASE